Research directory
Peptide compounds, organized by evidence and regulatory status
A curated reference of peptide research compounds drawn from public biomedical databases. Each entry lists mechanism summaries, regulatory status, evidence quality, safety flags, and links to peer-reviewed literature — never dosing, protocols, or sourcing.
Epithalon
Alanyl-Glutamyl-Aspartyl-Glycine (AEDG tetrapeptide)
Synthetic tetrapeptide studied by the Khavinson research group for putative telomerase activation and pineal-modulating effects. Independent replication is limited.
FOXO4-DRI
Longevity & Anti-Aging reference entry
Senolytic peptide that disrupts FOXO4–p53 interaction; studied in aged mice for clearance of senescent cells. No human clinical data.
Humanin
Apoptosis regulator BAX
Mitochondrial-derived peptide studied in neuroprotection and metabolic regulation; early correlational human data.
MOTS-c
Cyclic AMP-dependent transcription factor ATF-1
Studied for metabolic regulation, insulin sensitivity, and exercise adaptation in animal models and early human pharmacokinetic studies.
SS-31
Elamipretide
Mitochondrially targeted cardiolipin-binding peptide studied in Phase 2 trials for heart failure, kidney injury, and primary mitochondrial myopathy.
Thymalin
Thymic peptide bioregulator extracted from calf thymus.
Thymic peptide complex with limited Eastern European clinical reports in elderly and immunocompromised populations.